Edgestream Partners, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Edgestream Partners, L.P.

$2.88 Billion
Q1 2025

A detailed history of Edgestream Partners, L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 2,249 shares of REGN stock, worth $1.35 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,249

Previous 8,822 74.51%

Holding current value

$1.35 Million

Previous $6.28 Million 77.31%

% of portfolio

0.05%

Previous 0.27%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$634.14 - $744.83 $4.17 Million - $4.9 Million	-6,573 Reduced 74.51%	2,249 $1.43 Million
Q4 2024 Feb 06, 2025	BUY	$701.85 - $1046.91 $5.95 Million - $8.87 Million	8,475 Added 2442.36%	8,822 $6.28 Million
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $4.99 Million - $5.85 Million	-4,870 Reduced 93.35%	347 $364,000
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $2.14 Million - $2.59 Million	-2,422 Reduced 31.71%	5,217 $5.48 Million
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $6.9 Million - $7.59 Million	7,639 New	7,639 $7.35 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $316,449 - $385,877	457 Added 54.4%	1,297 $1.07 Million
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $588,025 - $697,494	840 New	840 $603,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $4.48 Million - $4.87 Million	-6,351 Reduced 95.56%	295 $212,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $1.24 Million - $1.56 Million	2,155 Added 47.98%	6,646 $4.58 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $446,905 - $602,154	815 Added 22.17%	4,491 $2.66 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $2.19 Million - $2.57 Million	3,676 New	3,676 $2.57 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $863,046 - $1.07 Million	-1,588 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $911,559 - $1.08 Million	1,588 New	1,588 $961,000
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $2.28 Million - $2.9 Million	-4,764 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$544.75 - $658.21 $2.6 Million - $3.14 Million	4,764 New	4,764 $2.67 Million

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

87M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $64.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Regeneron Pharmaceuticals, Inc. Transaction History